(Date:12/3/2009)... (NYSE: IMA ), a global leader in enabling ... the merger of rapid diagnostics and health management, has declared ... Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will be ... per share equal to the quotient of (a) $3.00 divided ...
(Date:12/2/2009)... (Nasdaq: MATK ) announced today that it intends to ... 2009 on December 16, 2009, at approximately 4:00 p.m. Eastern ... Martek will conduct a conference call to discuss these results ... call live via webcast by visiting Martek,s web site at ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... concept demonstration tires made with BioIsoprene technology, ... in the manufacture of synthetic rubber with renewable biomass, ... tire will be on display at a lounge in ... throughout December 21, while the other tire will make ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... & Renshaw 10th Annual Healthcare Conference on,Tuesday, November ... will be held at,the New York Palace Hotel ... about this conference, please visit:, http://www.rodmanandrenshaw.com/conferences?id=19 , ...
... EDMONTON, Nov. 5 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: ... today,announced that Mr. Kevin Giese, President and CEO, will present ... York., WHEN: Monday November ... New York Palace Hotel, New York., About BioMS Medical ...
... /PRNewswire/ - Trillium Therapeutics Inc., a privately,held ... Dr.,Michael Berendt and Dr. John Dietrich have ... Dr. Michael Moore commented: "It is a ... executives to the Board,where they will enhance ...
Other Biology Technology:BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference 2Trillium Strengthens its Board of Directors 2sTNF-receptor I Polyclonal Antibody 100 ug affinity purified rabbit anti-human sTNF-receptor I polyclonal antibody. Performs well in WB/Elisa/Neutralization....
...
Smac/DIABLO (CT) - IgG for Western Blotting, Host: Rabbit Family: Smac/DIABLO...
Mouse monoclonal [ICRF 44] to Integrin alpha M...
Biology Products: